TMS Health Solutions Opens Second Depression Treatment Facility in San Francisco, Expanding the Company’s Practice to Four Clinics in Northern California

New office to be staffed with four psychiatric professionals providing “Solutions Beyond Medication” for patients suffering from treatment-resistant depression

San Francisco, Calif., (June 22, 2016) – TMS Health Solutions today announced it has further expanded its practice to include a second clinic in San Francisco, bringing the company’s practice to four depression treatment centers in Northern California. Dr. Richard Bermudes, the company’s Chief Medical Officer, as well as a nationally-recognized authority on depression therapy and the current president of the Clinical TMS Society, will oversee the clinical treatment in all four locations.

TMS Health Solutions specializes in caring for patients suffering from treatment-resistant depression. TMS Health Solutions provides patients “Solutions Beyond Medication” by treating depression with medication management; however, they specialize in the delivery of Transcranial Magnetic Stimulation (TMS), a noninvasive treatment for those who do not respond to their treatment and/or medication. FDA-cleared TMS therapy utilizes magnetic pulses to precisely stimulate areas of the brain known to be the cause of depression and mood disorders, leaving none of the systemic side effects that come from taking oral anti-depressant medication. TMS sessions are administered in a physician’s office in a comfortable outpatient setting, and patients can resume normal activity immediately afterward.

The new TMS Health Solutions treatment center is centrally located across the street from Union Square at 360 Post Street, Suite 1000, in San Francisco.

“This new location helps us to meet the demand for quality insurance-based psychiatry services with a centralized location that provides convenient access for patients,” said Brad Hummel, CEO, TMS Health Partners, the business management company for TMS Health Solutions. “Additionally, this new facility will allow us to host educational forums for both patients and partner clinicians.”

TMS Health Solutions Board Certified Clinicians
The following clinicians will be accepting new patients at the new facility:

Sasha Bergeron, MSN, PMHNPBC, is a board-certified family psychiatric mental health nurse practitioner. Following her lifelong interest in psychology and community service, she decided to pursue a Master’s in Nursing, which would prepare her to provide both medication management and therapy. She received TMS training under Dr. Richard Bermudes and is particularly inspired by its effectiveness in helping patients achieve safe and effective relief or remission from the debilitating effects of major depressive disorder.

Sasha graduated from Vanderbilt University at the top of her class, earning the school’s Outstanding Student award. Her areas of expertise include ADHD; mood disorders especially unipolar and bipolar depression–anxiety disorders; and behavioral disorders, such as oppositional defiant disorder. In her clinical experience, Sasha has served patients across the lifespan in the inpatient, outpatient, and urban and rural community mental health settings.

Richard Bowdle, M.D., is a board-certified psychiatrist with more than 35 years of experience in holistic patient care, teaching, and organizational leadership. He maintained a private practice and is Assistant Clinical Professor VCF at the University of California Davis School of Medicine Department of Psychiatry. Dr. Bowdle has also headed behavioral care facilities throughout California, including serving as Medical Director at Sutter Center for Psychiatry and Chief of the Department of Psychiatry at Sutter Medical Center in Sacramento.

Dr. Bowdle earned his medical degree at the University of Florida, Gainesville in 1980, then completing training in internal medicine at St. Mary’s Hospital in San Francisco and a Psychiatric Residency at UCSF’s Langley Porter Institute.

Oana Galicki, M.D. is a board-certified psychiatrist with a strong psychopharmacologic background, as well as extensive training in various modalities of psychotherapy. She specializes in the treatment of mood and anxiety disorders and has a special interest in the impact of social, psychological, and behavioral factors on general health and quality of life.

Dr. Galicki has conducted research and published papers on subjects including treatment for depression in patients with Parkinson’s disease and Alzheimer’s disease prevention.

In addition to her most recently working in a private practice, Dr. Galicki also held positions at San Mateo Medical Center and St. Luke’s Roosevelt
Hospital in New York.

Dr. Galicki received her medical degree from the “Carol Davila” University of Medicine and Pharmacy in Bucharest, Romania. She completed her Adult Psychiatry Residency and her Psychosomatic Medicine Fellowship at St. Luke’s Roosevelt Hospital in New York.

Joshua E. Kuluva, M.D., a board-certified psychiatrist, has been the department head of neurology at Alta Bates Medical Center for the last several years. He is interested in novel approaches in the treatment of neuropsychiatric conditions.

Dr. Kuluva has a specialty in the treatment of the post-concussive syndrome and has been working closely with both athletes and the general population who are coping with the neuropsychiatric aspects of this condition. He has experience with both Cognitive Behavioral Therapy and Psychodynamic Psychotherapy. He also treats patients with neurologic disorders who are experiencing psychiatric symptoms such as elderly patients with cognitive issues and depression, or adults with developmental delays and behavior concerns.

Dr. Kuluva received his medical degree from Sackler School of Medicine in Tel Aviv University, Israel. He completed his MIRECC-Traumatic Brain Injury fellowship at Mt. Sinai School of Medicine in New York and a mini-fellowship J. Kiffin Penry Epilepsy at Wake Forest University in Winston-Salem. He completed his residencies in Neurology and Psychiatry at the New York University School of Medicine.

About TMS Therapy
Cleared by the FDA in 2008, TMS is a drug-free, non-invasive therapy for patients who suffer from treatment-resistant depression. It is administered in a physician’s office in an outpatient setting. By using an MRI-strength magnetic field to stimulate the prefrontal cortex of the brain, the core symptoms of major depression can be addressed. Unlike antidepressants or electroconvulsive therapy (ECT), patients undergoing TMS therapy experience minimal side effects.